Aug 2026· European Journal of Endocrinology· Vol 195· 0 citations
TL;DR
Mice with senescent CD4+ T cells displayed reduced bone mineral density and impaired structural integrity, likely due to enhanced osteoclastic activity at the expense of osteoblast function, combined with diminished responsiveness to hormonal regulation resulting from decreased receptor expression.
Abstract
Bone serves as the primary reservoir of calcium and phosphorus in the body and undergoes continuous remodeling. During aging or in conditions of calcium and phosphorus imbalance caused by physiological or pathological processes, bone resorption may increase, negatively impacting bone density. Calcium and bone homeostasis are regulated by several hormones, including PTH, calcitonin, calcitriol, and FGF23, produced in different organs. Inflammaging, a state of low-grade chronic inflammation associated with aging, is considered a risk factor for age-related diseases such as osteoporosis. Accumulation of senescent cells during aging can impair tissue function through the development of a Senescence-Associated Secretory Phenotype (SASP). Mice lacking expression of the mitochondrial gene Tfam specifically in CD4+ T cells exhibit T cell senescence and a premature aging phenotype. In this study, we investigated how senescent CD4+ T cells influence bone remodeling.
Gene expression was analyzed by real-time PCR in tibiae from CD4-TFAM mice (Tfamfl/fl Cd4Cre/Cre) and control littermates, kindly provided by Dr. Mittelbrunn's research group (Centro de Biología Molecular Severo Ochoa, Madrid, Spain). Bone morphology was assessed using micro-computed tomography (micro-CT). Additionally, MLO-Y4 cells, an osteocyte model, were treated with 1% serum from CD4-TFAM or control mice, and gene expression was analyzed by real-time PCR.
CD4-TFAM mice exhibited significantly lower bone mineral density and compromised bone structural integrity compared with controls. In bone tissue, the OPG/RANKL ratio and expression of osteocyte (osteocalcin) and osteoblast markers (alkaline phosphatase and Runx2) were reduced in CD4-TFAM mice. Expression of hormone receptors such as PTH1R and VDR was also significantly lower, whereas FGF23 expression was higher in CD4-TFAM mice. MLO-Y4 cells treated with serum from CD4-TFAM mice showed significantly increased RANKL expression, while VDR expression remained unchanged compared to cells treated with control serum.
Mice with senescent CD4+ T cells displayed reduced bone mineral density and impaired structural integrity, likely due to enhanced osteoclastic activity at the expense of osteoblast function, combined with diminished responsiveness to hormonal regulation resulting from decreased receptor expression.
A structured research roadmap is proposed—centered on fate-mapping, lineage-specific depletion, and single-cell multi-omics—to convert the prevailing hypothesis into experimentally testable and clinically actionable evidence, while delineating the translational challenges that must be overcome to achieve precision seno...
Min-Shun Zhu, Jie Zhang, Hou-Shan Fang et al.· Frontiers in Endocrinology· 0 citations
Aging-related bone diseases are often interpreted through hormonal decline, defective remodeling, and chronic low-grade inflammation, yet these accounts do not fully capture the cellular, spatial, and temporal heterogeneity of skeletal aging. Bone is an immune-active organ sustained by coordinated signaling among skele...
Lan Zhang, Yao Yao, Jin-Xu Chen· Frontiers in Immunology· 0 citations
Chronic kidney disease (CKD) disrupts mineral metabolism, skeletal remodeling, vascular homeostasis, and immune regulation, producing the systemic phenotype of CKD-mineral and bone disorder (CKD-MBD) together with chronic inflammation and impaired host defense. Osteoimmunology provides a framework for understanding how...
Cai-Mei Zheng, Hsuan-Chu Hsu, Yi-Chou Hou et al.· Frontiers in Immunology· 0 citations
A gut bone inflammatory framework for exercise-associated skeletal protection in aging is supported by a D-galactose aging rat model and osteoblast-like cell experiments to examine exercise-associated changes in trimethylamine N-oxide (TMAO) and inflammasome signaling.
Postmenopausal osteoporosis (PMOP) is a prevalent female bone disease. It can progress to fractures at advanced stages and raise disability risks.
This study evaluated the value of EPB41L4A-AS1 in PMOP diagnostic and fracture risk prediction, and explored its mechanism of regulating osteogenic differentiat...
Yi-Wei Wang, Xin-Tong Hao, Enxiong Liu et al.· Hereditas· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.